Our goal is to expand the range of treatment options available to patients by pairing the POD technology with pharmaceuticals and biotechnology products.
Impel works with our partners to support pre-clinical development of partner molecules within the POD device, including device optimization and formulation development. As innovators in nose-to-brain drug delivery, our expertise complements your research and development program by providing collaborative support in study design, execution, and analysis.
We offer a readily scalable technology that may allow more potential therapeutic compounds to enter clinical development and progress through the product pipeline.
We have clinical supplies of the POD device and can assist in compilation of regulatory filings regarding the device technology.